Abstract Background -T cell response to mycobacterial antigens may be directed against those antigens common to all mycobacteria (group i), those restricted to slow (group ii) or fast growers (group iii), or those which are species-or subspeciesspecific (group iv). These responses were assessed by skin testing patients infected with the human immunodeficiency virus (HIV) and healthy controls with reagents derived from different strains ofmycobacteria. Methods -Skin test responses to new tuberculins prepared from Mycobacterium tuberculosis, M avium serotypes 4 and 8, and either M intracellulare or M flavescens antigens were evaluated prospectively in 51 HIV infected patients and 67 healthy controls.
Results -Assessment of induration at 72 hours showed absence of skin test response to common mycobacterial antigens in all 27 HIV positive patients with CD4 counts of > 400/mm3 (range 400-1594, median 540) compared with 27% reactivity in controls; complete anergy was demonstrated in 24 patients with CD4 counts of < 400/mm3. By contrast, no difference in species or subspecies-specific responses was found between healthy controls and HIV positive patients with CD4 counts of ¢ 400/mm3. Conclusions -Subsets of CD4 + T helper cells are instrumental in determining the balance between cell-mediated and humoral immunity. One T helper subset (TH1) produces cytokines that increase cellular immunity and is stimulated by group i common mycobacterial antigens. Lack Infections with many mycobacterial species have been identified in association with HIV but only M tuberculosis and M avium are seen frequently. HIV-associated tuberculosis can occur at any stage of the disease, the clinical presentation depending on the CD4 count and whether infection is primary or due to reactivation. By contrast, M avium is only seen in the later stages of HIV infection when the CD4 count is low (< 100/mm3) and then it presents as a disseminated disease. Whether M avium disease is due to reactivation of previously acquired infection or to new infection is unclear.
In favour of reactivation is the highly significant association of certain M avium serotypes (1, 4, and 8) with disease in HIV;' these strains appear distinct from those causing disease in most patients uninfected with HIV and isolates from the environment. In addition, both T cell and B cell responses have been described in non-HIV infected healthy persons against M avium infection indicating past exposure and skin sensitisation. or may be due to responsiveness to slow grower associated antigens (table 1) , as shown in a Kuwaiti population. " All four reagents used in the major part of our study were prepared from slow growing species containing group ii antigens as shown in table 1. Individuals who respond to all of them may have done so through cellular recognition of either common mycobacterial or slow grower associated antigens, and the additional control group tested with F, prepared from the fast grower M flavecesens, which lacks group ii antigens, were included to resolve this. Our results show complete absence of skin test responses to common mycobacterial antigens in HIV seropositive patients unrelated to their CD4 cell counts. T cell recognition of these antigens is associated with protective immunity, probably represents a TH1 mediated response,'3 and the lack of such responses in our patients may partly explain the increased susceptibility to tuberculosis even at early stages of HIV disease (CD4 count ¢ 400/ mm3). Responsiveness to other mycobacterial antigens does depend on T cell count since there is a significant difference in responses to them between patients with more than or less than 400 CD4 cells/mm3.
Although it is customary to assume that immune changes found in HIV seropositive individuals are the result of immunodeficiency induced by the virus, the possibility has to be considered that they may be a marker of HIV susceptibility as suggested by recent serological findings. 4 Hence, lack of cellular responsiveness to common mycobacterial antigens may reflect the pivotal role of TH 1 cells in protection from HIV infection. A body of circumstantial evidence is accumulating that cellular responses to these mycobacterial antigens,'5 which include the major stress proteins, are mediated through THI rather than TH2 cells. Recognition of common mycobacterial antigens may therefore be a simple marker of protection from HIV disease, a viewpoint in agreement with that of Clerici and Shearer relating to T cell function and disease susceptibility. 16 Serotyping is dependent on chemically distinct surface glycolipids. The There was no significant difference between responders to species-specific antigens in both the HIV seropositive individuals and healthy controls, suggesting that our results are not explained by non-specific loss of cutaneous delayed type hypersensitivity -for example, to mumps and tetanus toxoid antigens -in HIV positive patients with CD4 counts of i 400/ 3 18 mm.
However, when examining patients with HIV infection there is a higher proportion of responders to serotype 4 than to serotype 8, which mirrors the relative prevalence of these serotypes amongst M avium strains recovered from patients with HIV infection in the UK.
Responsiveness to common mycobacterial antigens (and hence protective immunity) can be boosted by BCG or killed M vaccae. Immunotherapy with killed M vaccae has been shown previously to enhance T cell recognition of common mycobacterial antigens in adults with lepromatous leprosy or pulmonary tuberculosis as judged by skin test and lymphocyte transformation tests. 
